ResearcherSeoul National UniversityActive in the last 2 years
Boram Lee
Matched on ORCID iD 0000-0003-1567-1774; OpenAlex author ID A5100385564. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 2 papers
Papers 7
- "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. Co-author DOI 10.1016/j.hpb.2025.03.450↗
- Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, and Oral Immunosuppression. Co-author DOI 10.3390/medicina61040586↗
- Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study. Co-author DOI 10.1016/j.pan.2024.03.013↗
- Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthine) in urine First author DOI 10.21203/rs.3.rs-5011761/v1↗
- Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival a… Co-author DOI 10.1245/s10434-022-13043-5↗
- Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. Co-author DOI 10.4251/wjgo.v15.i6.911↗
- Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type. Co-author DOI 10.1097/as9.0000000000000096↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoo‐Seok Yoon · 7 shared papers, 2021–2025 · strength 1.59
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthi… DOI 10.21203/rs.3.rs-5011761/v1↗
- Ho‐Seong Han · 7 shared papers, 2021–2025 · strength 1.59
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthi… DOI 10.21203/rs.3.rs-5011761/v1↗
- MeeYoung Kang · 5 shared papers, 2023–2025 · strength 1.21
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthi… DOI 10.21203/rs.3.rs-5011761/v1↗
- Yeshong Park · 4 shared papers, 2023–2025 · strength 0.95
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: … DOI 10.1016/j.pan.2024.03.013↗
- Jun Suh Lee · 4 shared papers, 2021–2025 · strength 0.83
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. DOI 10.4251/wjgo.v15.i6.911↗
- Paper Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes Accord… DOI 10.1097/as9.0000000000000096↗
- Jinju Kim · 2 shared papers, 2024–2025 · strength 0.50
- Jai Young Cho · 2 shared papers, 2023–2025 · strength 0.45
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 201… DOI 10.1245/s10434-022-13043-5↗
- Jin Peng He · 1 shared paper, 2024 · strength 0.26
- Yeon Bi Han · 1 shared paper, 2024 · strength 0.20
- Haeryoung Kim · 1 shared paper, 2024 · strength 0.20
- Roberto Ivan TROISI · 1 shared paper, 2023 · strength 0.19
- Fabrizio Panaro · 1 shared paper, 2023 · strength 0.19
- Gianluca Cassese · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.